Synthesis, Crystal Structure, DFT Calculations, Hirshfeld Surface Analysis and In Silico Drug-Target Profiling of ()-2-(2-(1,3-Dioxoisoindolin-2-yl)propanamido)benzoic Acid Methyl Ester.

The work here reflects synthesis, DFT studies, Hirshfeld charge analysis and crystal data exploration of pharmacologically important ()-2-(2-(1,3-dioxoisoindolin-2-yl)propanamido)benzoic acid methyl ester () to understand its properties for further chemical transformations. The methyl anthranilate () was produced by the esterification of anthranilic acid in an acidic medium. The phthaloyl-protected alanine () was rendered by the fusion of alanine with phthalic anhydride at 150 °C, followed by coupling with () furnished isoindole (). The characterization of products was performed using IR, UV-Vis, NMR and MS. Single-crystal XRD also verified the structure of () in which N-H⋯O bonding stabilizes the molecular configuration of (), resulting in the formation of S(6) hydrogen-bonded loop. The molecules of isoindole () are connected in the form of dimers, and the π⋯π stacking interaction between aromatic rings further stabilizes the crystal packing. DFT studies suggest that HOMO is over the substituted aromatic ring, the LUMO is present mainly over the indole side, and nucleophilic and electrophilic corners point out the reactivity of the product (). In vitro and in silico analysis of () shows its potential as an antibacterial agent targeting DNA gyrase and Dihydroorotase from and tyrosyl-tRNA synthetase and DNA gyrase from .